Shayeda
Publications by Shayeda
4 publications found • Active 2012-2017
2017
2 publicationsBuccal delivery of Isradipine from mucoadhesive buccal tablets
The present research work describes the  improvement of bioavailability of Isradipine through buccal delivery. Isradipine buccal tablets were prepared with β cyclodextrin which improved the photostability of the drug. Buccal formulations were evaluated for in vitro release, moisture absorption, mechanical properties, and bioadhesion, and optimized formulation was subjected for bioavailability studies in healthy human volunteers and compared with marketed tablet. The pharmacokinetic parameters Cmax, tmax and AUCo-t of test formulation were calculated and compared with the reference i.e., marketed product. It was observed from the study that the drug release from the test formulation could be sustained and it was concluded that the test formulation was able to sustain the drug release as compared to reference marketed product with 1.672 fold increase in extent of absorption i.e., AUC0-t.
Development and Evaluation of Push Pull Based Osmotic Delivery System for Ketorlac Tromtamine
To develop and evaluate Push Pull Osmotic tablets of ketorolac Tromethamine (KT). Core tablets of KT were formulated by wet granulation method using polymers (HPMC K4M, K15M) , coated with semipermeable membrane (cellulose acetate), plasticizer (PEG 400) , pore former (D- sorbitol) and osmogen (sodium chloride). Compatibility studies were carried out using Differential Scanning Calorimetry(DSC), no incompatibility between the drug and polymers observed. The Physical properties of tablets were evaluated for thickness, hardness, friability, drug content, effect of osmotic agent, percentage of pore former, pH, agitational intensity, weight gain, osmotic pressure and in vitro drug release for 12 hours. Release studies best fitted to zero order pattern, indicating drug release was non-Fickian, independent of pH and agitational intensity. The system is simple, cost effective and alternative to conventional osmotic pump since sophisticated laser drilling technique is not required.
2015
1 publicationPreparation, Characterization and Evaluation of Anti-inflammatory Activity of Dexamethasone Topical Liposomal Gel Formulation
The aim of the study was to prepare and evaluate topical gels incorporating liposomes of Dexamethasone base. Multilamellar vesicular (MLVs) liposomes were prepared using thin film hydration method. By subjecting MLVs to sonication using Ultra homogenizer, SUVs were formed. Liposomes were composed of soya lecithin, cholesterol, and dexamethasone. Using these method different concentrations of dexamethasone liposomes were prepared and were successfully incorporated in 1% carbopol gels. Liposomes were characterized for their particle size using zeta sizer and entrapment efficiency by dialysis method. SUVs were evaluated for in vitro release. Viscosity of gel formulations was measured using Brookfield viscometer, Drug lipid compatibility was performed using FTIR spectroscopy. Liposomal gels were evaluated for in vitro release studies, ex-vivo permeation studies and pharmacodynamic studies (Anti-inflammatory activity). Results showed more localized and sustained effect with Liposomal dexamethasone gels than dexamethasone gel formulation.
2012
1 publicationFormulation and Ex Vivo Evaluation of Buccal Tablets of Eletriptan Hydrobromide
The objective of this study was to develop effective buccoadhesive bilayered tablets of Eletriptan hydrobromide containing bioadhesive layer and drug free backing layer, expected to release the drug in unidirectional for extended period of time. Buccoadhesive tablets were prepared by using HPMC K4M, Carbopol 941NF and Carbopol 974p as mucoadhesive polymers with varying concentrations. The formulations were tested for in-vitro drug release, bioadhesive strength, moisture absorption, residence time and drug permeation through porcine buccal mucosa. Optimized formulation F3 of HPMC K4M showed maximum release of the drug (97.83±0.41), best fit in the peppas model and permeated 73.52% of the drug through porcine buccal membrane.
